As a multi-receptor agonist, Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, enhancing weight loss, improving glucose regulation, and supporting lipid metabolism
Semaglutide is a GLP-1 receptor agonist, which means it acts like glucagon-like peptide-1, a hormone involved in appetite, fullness, digestion and blood sugar regulation
Regular medical follow-up To achieve the expected results, you must follow up with your doctor to ensure your safety and the effectiveness of the treatment, whether oral or intravenous
Theyre usually worse just after a dose increase and often settle within a few weeks
A mix of daily steps, cardio, and strength training can improve overall results and body composition